134 related articles for article (PubMed ID: 17445532)
1. Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis.
Anan F; Shimomura T; Imagawa M; Masaki T; Nawata T; Takahashi N; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2007 May; 56(5):593-8. PubMed ID: 17445532
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis.
Anan F; Takahashi N; Shimomura T; Imagawa M; Yufu K; Nawata T; Nakagawa M; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2006 May; 55(5):656-61. PubMed ID: 16631443
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein level is a significant risk factor for silent cerebral infarction in patients on hemodialysis.
Anan F; Shimomura T; Kaku T; Kaneda K; Imagawa M; Tsukagawa H; Masaki T; Nawata T; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
Metabolism; 2008 Jan; 57(1):66-70. PubMed ID: 18078860
[TBL] [Abstract][Full Text] [Related]
4. Monocyte chemoattractant protein-1 is associated with silent cerebral infarction in patients on haemodialysis.
Uchida E; Anan F; Masaki T; Kaneda K; Nawata T; Eshima N; Saikawa T; Yoshimatsu H
Intern Med J; 2012 Jan; 42(1):29-34. PubMed ID: 21627744
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and silent cerebral infarction in hemodialysis patients: a cross-sectional study.
Kikuchi H; Anan F; Kaneda K; Nawata T; Eshima N; Saikawa T; Yoshimatsu H
Eur J Neurol; 2011 Apr; 18(4):625-30. PubMed ID: 21040233
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients.
Fukunaga N; Anan F; Kaneda K; Nawata T; Saikawa T; Yoshimatsu H
Metabolism; 2008 Oct; 57(10):1323-7. PubMed ID: 18803933
[TBL] [Abstract][Full Text] [Related]
7. [Blood serum hepatocyte growth factor in children with chronic renal failure treated with CAPD and HD].
Szprynger K; Szczepańska M; Morawiec-Knysak A; Dyduch A
Pol Merkur Lekarski; 2000 Apr; 8(46):270-1. PubMed ID: 10897645
[TBL] [Abstract][Full Text] [Related]
8. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis.
Kawamura M; Fijimoto S; Hisanaga S; Yamamoto Y; Eto T
Am J Kidney Dis; 1998 Jun; 31(6):991-6. PubMed ID: 9631844
[TBL] [Abstract][Full Text] [Related]
9. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors in non-diabetic hemodialysis patients: a comparative study.
Tzanatos HA; Tseke PP; Pipili C; Retsa K; Skoutelis G; Grapsa E
Ren Fail; 2009; 31(2):91-7. PubMed ID: 19212904
[TBL] [Abstract][Full Text] [Related]
11. Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration.
Christidou F; Bamichas G; Galaktidou G; Fragidis S; Gionanlis L; Frangia T; Bischiniotis T; Sombolos K
Ren Fail; 2008; 30(9):861-4. PubMed ID: 18925524
[TBL] [Abstract][Full Text] [Related]
12. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
13. Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.
Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Ebihara I; Koide H
Diabetes Metab Res Rev; 2005; 21(1):39-43. PubMed ID: 15386824
[TBL] [Abstract][Full Text] [Related]
14. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
Katerinis I; Nguyen QV; Magnin JL; Descombes E
Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
[TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
[TBL] [Abstract][Full Text] [Related]
16. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
18. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
19. Plasma fibrinogen, ambulatory blood pressure, and silent cerebrovascular lesions: the Ohasama study.
Aono Y; Ohkubo T; Kikuya M; Hara A; Kondo T; Obara T; Metoki H; Inoue R; Asayama K; Shintani Y; Hashimoto J; Totsune K; Hoshi H; Satoh H; Izumi S; Imai Y
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):963-8. PubMed ID: 17272746
[TBL] [Abstract][Full Text] [Related]
20. Silent cerebral infarction in hemodialysis patients.
Nakatani T; Naganuma T; Uchida J; Masuda C; Wada S; Sugimura T; Sugimura K
Am J Nephrol; 2003; 23(2):86-90. PubMed ID: 12481146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
